Results 191 to 200 of about 45,441 (213)

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

Lancet, The, 2016
Wojciech Jurczak, Mats Jerkeman, Marek Trneny   +2 more
exaly  

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

Lancet, The, 2016
Olivier Hermine, Eva Hoster, Jan A Walewski   +2 more
exaly  

Biclonal mantle cell lymphoma

Blood
Preetesh Jain, Fatima Zahra Jelloul
openaire   +2 more sources

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Lancet, The, 2018
Michael Wang, Simon A Rule, Pier Luigi Zinzani   +2 more
exaly  

Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage

Cancer Cell, 2016
Renée Beekman, Roser Vilarrasa-Blasi, Martí Duran-Ferrer   +2 more
exaly  

Oral cavity and oropharyngeal squamous cell carcinoma—an update

Ca-A Cancer Journal for Clinicians, 2015
Angela C Chi
exaly  

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma

New England Journal of Medicine, 2015
Peter Martin, Sonali M Smith, Jakub Svoboda   +2 more
exaly  

Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics

Nature Reviews Cancer, 2007
Pedro Jares, Dolors Colomer, ElÍas Campo   +2 more
exaly  

Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma

New England Journal of Medicine, 2015
Tadeusz Robak, Huiqiang Huang, Jun Zhu
exaly  

Mantle Cell Lymphoma

2014
F. Fend, L. Quintanilla-Martínez
openaire   +1 more source